cme group inc. - CME
CME
Close Chg Chg %
228.00 0.16 0.07%
Open Market
228.16
+0.16 (0.07%)
Volume: 76.80K
Last Updated:
Nov 21, 2024, 9:51 AM EDT
Company Overview: cme group inc. - CME
CME Key Data
Open $229.18 | Day Range 227.55 - 229.18 |
52 Week Range 190.73 - 230.74 | Market Cap $82.76B |
Shares Outstanding 360.36M | Public Float 359.14M |
Beta 0.56 | Rev. Per Employee N/A |
P/E Ratio 24.15 | EPS $9.52 |
Yield 426.72% | Dividend $1.15 |
EX-DIVIDEND DATE Dec 9, 2024 | SHORT INTEREST N/A |
AVERAGE VOLUME 1.66M |
CME Performance
1 Week | 1.94% | ||
1 Month | 0.59% | ||
3 Months | 10.92% | ||
1 Year | 5.74% | ||
5 Years | 11.00% |
CME Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
20
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | HOLD | Average Target Price | 237.813 | |
Number of Ratings | 20 | Current Quarters Estimate | 2.461 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | 10.214 | |
Last Quarter’s Earnings | 2.68 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 9.34 | Next Fiscal Year Estimate | 10.367 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 15 | 13 | 18 | 18 |
Mean Estimate | 2.46 | 2.55 | 10.21 | 10.37 |
High Estimates | 2.61 | 2.68 | 10.35 | 10.65 |
Low Estimate | 2.31 | 2.35 | 10.04 | 9.78 |
Coefficient of Variance | 3.61 | 3.07 | 0.85 | 2.34 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 7 | 7 | 7 |
OVERWEIGHT | 1 | 1 | 1 |
HOLD | 9 | 9 | 7 |
UNDERWEIGHT | 1 | 1 | 0 |
SELL | 2 | 2 | 3 |
MEAN | Hold | Hold | Hold |
SEC Filings for Cme Group Inc. - CME
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Cme Group Inc. - CME
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Sep 27, 2024 | William R. Shepard Director | 255,172 | Open market or private purchase of non-derivative security Non-derivative transaction at $218.5 per share | 55,755,082.00 |
Sep 27, 2024 | William R. Shepard Director | 2,360 | Open market or private purchase of non-derivative security Non-derivative transaction at $218.5 per share | 515,660.00 |
Jun 14, 2024 | Charles Peter Carey Director | 7,163 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $195.44 per share | 1,399,936.72 |
May 22, 2024 | Elizabeth A. Cook Director | 18,241 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $211.52 per share | 3,858,336.32 |
May 16, 2024 | Derek L. Sammann Sr MD Gl Hd Commodity & Option | 9,694 | Bona fide gift | 0.00 |
May 16, 2024 | Derek L. Sammann Sr MD Gl Hd Commodity & Option | 10,811 | Bona fide gift | 0.00 |
May 14, 2024 | Terry L. Savage Director | 17,441 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $210.65 per share | 3,673,946.65 |
May 9, 2024 | Hilda Harris Piell Sr MD & Chief HR Officer | 29,256 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $210.31 per share | 6,152,829.36 |
May 9, 2024 | Hilda Harris Piell Sr MD & Chief HR Officer | 32,566 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $210.38 per share | 6,851,235.08 |
May 9, 2024 | Hilda Harris Piell Sr MD & Chief HR Officer | 35,596 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $210.39 per share | 7,489,042.44 |
May 9, 2024 | Hilda Harris Piell Sr MD & Chief HR Officer | 36,096 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $210.4 per share | 7,594,598.40 |
May 2, 2024 | Terrence A. Duffy Chairman and CEO; Director | 103,379 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $209.52 per share | 21,659,968.08 |
May 2, 2024 | Terrence A. Duffy Chairman and CEO; Director | 67,455 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $211.44 per share | 14,262,685.20 |
May 2, 2024 | Terrence A. Duffy Chairman and CEO; Director | 92,671 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $210.2 per share | 19,479,444.20 |
Mar 20, 2024 | Julie Holzrichter Sr MD Chief Operating Officer | 38,416 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $217.5 per share | 8,355,480.00 |
Mar 20, 2024 | Julie Holzrichter Sr MD Chief Operating Officer | 41,766 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $217.5 per share | 9,084,105.00 |
Mar 20, 2024 | Kendal Vroman Chief Transformation Officer | 22,434 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $217.5 per share | 4,879,395.00 |
Mar 20, 2024 | Kendal Vroman Chief Transformation Officer | 20,089 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $217.5 per share | 4,369,357.50 |
Mar 20, 2024 | Kendal Vroman Chief Transformation Officer | 19,985 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $217.5 per share | 4,346,737.50 |
Mar 20, 2024 | Julie M. Winkler Sr MD Chief Commercial Officer | 34,187 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $217.5 per share | 7,435,672.50 |
Cme Group Inc. in the News
Chicago's corporate exodus serves as backdrop to DNC
Chicago has seen several high-profile departures of corporations moving their headquarters or significant portions of their operations out of the city in recent years.
CME denies CBOE merger report
Derivatives exchange giant CME Group has forcefully denied a report that it is in talks to acquire smaller Cboe Global Markets.